MedTrace Logo

PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases

NCT01805635 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5500

Last updated 2013-09-09

No results posted yet for this study

Summary

The aim of this study is to assess the influence of kind of allergic disease, allergic profile, allergen exposure, treatment method on lung function parameters, fractional exhaled nitric oxide level in children suspected and being diagnosed due to allergic diseases.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Iwona Stelmach, MDPhDProf · Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

  • Tomasz Grzelewski, MDPhD · Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01805635 on ClinicalTrials.gov